GYRE — GYRE THERAPEUTICS INC
As of Q2 2026, 17 SEC-registered investment managers reported holding GYRE (GYRE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $14.42M across 2.20M shares. That is +31.1% by share count (+522.73K shares) versus the previous quarter, while reported value moved +23.1%. Ownership is concentrated: the five largest holders account for 89.9% of reported value and the top ten for 97.2%.
Compared with the prior quarter, 3 opened new positions, 12 added to existing stakes, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
GYRE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.20M | $8.48M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 993.94K | $6.55M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 532.95K | $3.51M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 184.29K | $1.21M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 169.54K | $1.12M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 86.23K | $568.29K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 62.75K | $413.52K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 41.69K | $274.74K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2024 | 13.98K | $244.35K | 0.00% | New |
| Renaissance Technologies history | Q2 2024 | 13.90K | $165.83K | 0.00% | New |
| Marshall Wace history | Q2 2024 | 10.72K | $127.89K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 18.76K | $123.65K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 18.49K | $121.84K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 17.94K | $118.22K | 0.00% | Add |
| Lazard Asset Management history | Q3 2025 | 14.93K | $111.39K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 16.30K | $107.40K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 14.97K | $98.68K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 12.53K | $82.54K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 8.59K | $56.58K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 7.83K | $50.51K | 0.00% | New |
New Positions (Q2 2026)
- Millennium Management 18.49K sh · $121.84K
- JPMorgan Chase & Co 7.83K sh · $50.51K
- T. Rowe Price Associates 15.03K sh · $100
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | 514.42K | 531.68K | 547.21K | 842.61K | 659.40K | 720.29K | 758.63K | 993.94K |
| Geode Capital Management | 134.43K | 160.59K | 259.81K | 303.65K | 304.10K | 312.32K | 401.71K | 374.62K | 423.22K | 431.41K | 532.95K |
| Charles Schwab Investment Management | — | — | 23.09K | 113.65K | 114.57K | 111.42K | 129.42K | 123.39K | 169.16K | 165.24K | 184.29K |
| Northern Trust Corp | 24.61K | 24.07K | 32.70K | 94.76K | 103.38K | 108.01K | 143.33K | 116.34K | 128.85K | 133.84K | 169.54K |
| Goldman Sachs Group | — | 46.09K | — | 18.80K | 26.39K | 16.15K | — | 18.03K | 31.11K | 73.12K | 86.23K |
| BNY Mellon | — | — | 18.27K | 12.51K | 13.90K | 16.49K | 23.99K | 24.40K | 41.20K | 43.14K | 62.75K |
| Morgan Stanley | — | 5.71K | 7.27K | 18.22K | 15.24K | 14.03K | 35.26K | 8.98K | 54.50K | 8.64K | 41.69K |
| UBS Group AG | 333 | — | 2.12K | 3.64K | 57.08K | 24.31K | 8.64K | 22.96K | 9.58K | 21.09K | 18.76K |
| Millennium Management | — | 60.32K | — | — | — | — | — | 35.75K | — | — | 18.49K |
| Deutsche Bank AG | — | — | — | — | — | — | 10.93K | 10.93K | 10.61K | 10.61K | 17.94K |
| Wells Fargo & Co | 94 | 96 | 2.99K | 3.10K | 4.02K | 4.11K | 7.01K | 5.56K | 12.92K | 4.29K | 16.30K |
| Fidelity Management & Research (FMR) | — | — | — | 3.74K | 1.26K | 376 | 10.89K | 10.20K | 10.30K | 18.72K | 14.97K |
| Bank of America Corp | — | — | 4.97K | 4.94K | 6.94K | 4.88K | 6.28K | 6.69K | 9.76K | 10.54K | 12.53K |
| Citigroup Inc | 7.75K | 12.17K | 1.56K | 5.08K | 5.40K | 4.85K | 5.94K | 384 | 268 | 629 | 8.59K |
| JPMorgan Chase & Co | 292 | 20.03K | 2.98K | 3.03K | 3.27K | 3.50K | 6.46K | 3.69K | 5.11K | — | 7.83K |
| Legal & General Investment Management America | — | — | 603 | 603 | 603 | 603 | 1.51K | 860 | 1.41K | 1.25K | 2.05K |
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | — | 15.03K |
| Lazard Asset Management | — | — | — | — | — | 833 | — | 14.93K | — | — | — |
| Vanguard Group | 198.10K | 195.10K | 231.64K | 340.17K | 322.46K | 1.10M | 1.15M | 1.15M | 1.20M | — | — |
| Renaissance Technologies | 17.09K | — | 13.90K | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details